ES2496892T3 - Formulaciones para el tratamiento de trastornos del tracto respiratorio superior - Google Patents

Formulaciones para el tratamiento de trastornos del tracto respiratorio superior Download PDF

Info

Publication number
ES2496892T3
ES2496892T3 ES11778814.1T ES11778814T ES2496892T3 ES 2496892 T3 ES2496892 T3 ES 2496892T3 ES 11778814 T ES11778814 T ES 11778814T ES 2496892 T3 ES2496892 T3 ES 2496892T3
Authority
ES
Spain
Prior art keywords
formulations
treatment
respiratory tract
upper respiratory
tract disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11778814.1T
Other languages
English (en)
Inventor
Ezio Bombardelli
Massimo Ronchi
Paolo Morazzoni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Application granted granted Critical
Publication of ES2496892T3 publication Critical patent/ES2496892T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Formulaciones que comprenden: a) extracto de Vaccinium myrtillus u otras especies ricas en antocianósidos; b) extracto de Punica granatum; c) extracto de Echinacea; y opcionalmente d) extracto de Krameria triandra.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES11778814.1T 2010-10-11 2011-10-05 Formulaciones para el tratamiento de trastornos del tracto respiratorio superior Active ES2496892T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20101852 2010-10-11
ITMI2010A001852A IT1402018B1 (it) 2010-10-11 2010-10-11 Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
PCT/EP2011/067357 WO2012049045A1 (en) 2010-10-11 2011-10-05 Formulations for the treatment of disorders of the upper respiratory tract

Publications (1)

Publication Number Publication Date
ES2496892T3 true ES2496892T3 (es) 2014-09-22

Family

ID=43737984

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11778814.1T Active ES2496892T3 (es) 2010-10-11 2011-10-05 Formulaciones para el tratamiento de trastornos del tracto respiratorio superior

Country Status (20)

Country Link
US (1) US9168276B2 (es)
EP (1) EP2627345B1 (es)
JP (2) JP6250397B2 (es)
KR (1) KR101870979B1 (es)
CN (1) CN103189065B (es)
AR (1) AR083366A1 (es)
AU (1) AU2011315708B2 (es)
BR (1) BR112013008771B1 (es)
CA (1) CA2814312C (es)
DK (1) DK2627345T3 (es)
ES (1) ES2496892T3 (es)
IL (1) IL225668A (es)
IT (1) IT1402018B1 (es)
MX (1) MX342986B (es)
PL (1) PL2627345T3 (es)
PT (1) PT2627345E (es)
RU (1) RU2580643C2 (es)
SG (1) SG189345A1 (es)
SI (1) SI2627345T1 (es)
WO (1) WO2012049045A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6075526B2 (ja) * 2012-07-04 2017-02-08 アサヒビール株式会社 ビール又はビール様飲料及びその製造方法
HUE036594T2 (hu) * 2012-10-18 2018-07-30 Montero Gida Sanayi Ve Ticaret As Növényi kivonatokat tartalmazó új kiszerelések
CN104304548A (zh) * 2014-10-27 2015-01-28 陈国勇 一种预防感冒茶及其制备方法
EP3103465A1 (en) 2015-06-10 2016-12-14 Raman Mehta Formulations for the treatment of mucosal lesions
EP3103464A1 (en) 2015-06-10 2016-12-14 Raman Mehta Formulations for the treatment of disorders of the mouth, throat and respiratory tract
US11207414B2 (en) 2015-09-22 2021-12-28 Graphium Biosciences, Inc. Cannabinoid glycoside prodrugs and methods of synthesis
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
EP3634390B1 (en) 2017-05-09 2023-09-27 Graphium Biosciences, Inc. Antimicrobial compositions comprising cbd or thc against c. difficile infection or e. faecalis
US12076357B2 (en) 2019-03-29 2024-09-03 Evonik Operations Gmbh Preparations containing berry extracts for use in the prophylaxis and/or treatment of viral infections caused by Paramyxoviridae
JP7523460B2 (ja) * 2019-03-29 2024-07-26 エボニック オペレーションズ ゲーエムベーハー アントシアニン組成物と抗ウイルス剤とを含む組み合わせ製剤
WO2020201055A1 (en) * 2019-03-29 2020-10-08 Evonik Operations Gmbh Preparations containing berry extracts for use in the prophylaxis and/or treatment of viral infections caused by pneumoviridae
KR102232733B1 (ko) * 2019-04-16 2021-03-26 주식회사 파미니티 에키네시아 추출물을 포함하는 항바이러스용 조성물
IT201900024997A1 (it) * 2019-12-20 2021-06-20 Dymalife Res S R L Associazione per uso nel trattamento e/o prevenzione degli stati influenzali e delle affezioni delle alte vie respiratorie
IT202000018949A1 (it) 2020-08-03 2022-02-03 Arterra Bioscience S P A Estratto derivato da bucce di punica granatum per la prevenzione e il trattamento di infezioni virali
WO2025084941A1 (ru) * 2023-10-16 2025-04-24 Общество С Ограниченной Ответственностью "Сплат Глобал" Сохранение свойств растительных масел

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07106972B2 (ja) * 1987-04-24 1995-11-15 佐藤製薬株式会社 歯科口腔用薬剤
ES2185310T3 (es) * 1998-01-30 2003-04-16 Rhinopharma As Agente antivirico herbario.
JP2000136141A (ja) * 1998-10-30 2000-05-16 Sumitomo Forestry Co Ltd 抗菌剤
US6241975B1 (en) * 1999-07-24 2001-06-05 Pacific Corporation Method for preparation of plant extract powder
JP2001122795A (ja) * 1999-10-27 2001-05-08 Nissui Pharm Co Ltd 感染性疾患予防・治療剤
IL143318A0 (en) * 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
CN1164299C (zh) * 2001-09-07 2004-09-01 张印昌 治疗急慢性炎症的中药制剂克炎口服液及制作方法
JP2003113013A (ja) * 2001-09-28 2003-04-18 Lion Corp 植物性抗菌防腐剤
JP4444593B2 (ja) * 2003-08-21 2010-03-31 日本メナード化粧品株式会社 抗菌剤
ITMI20032287A1 (it) 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento delle affezioni del cavo orale e delle prime vie respiratorie
ITMI20042414A1 (it) * 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
CN101057953A (zh) * 2006-04-21 2007-10-24 陈祖辉 对付病毒感染疾患的多靶协同防治制剂
WO2007133721A2 (en) * 2006-05-12 2007-11-22 Interleukin Genetics, Inc. Food compositions and methods of treating periodontal disease
WO2008024543A2 (en) * 2006-06-01 2008-02-28 Pom Wonderful, Llc Method of using composition comprising pomegranate extracts against influenza
US7820207B2 (en) * 2007-03-15 2010-10-26 Omnica Gmbh Stabilized anthocyanin compositions
US20090035226A1 (en) * 2007-07-31 2009-02-05 Phenolics, Llc Use of cranberry extract enriched in total phenols and free, essentially free, or substantially free of sugars, acids, sulfur and other contaminants, for periodontal treatment
KR20100134685A (ko) * 2008-04-24 2010-12-23 인데나 에스.피.에이 구강 감염의 치료 및 예방을 위한 조성물
US20090306025A1 (en) * 2008-05-30 2009-12-10 Fairfield Clinical Trials, Llc Method and composition for skin inflammation and discoloration
US9101604B2 (en) * 2008-06-05 2015-08-11 Indena S.P.A. Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes

Also Published As

Publication number Publication date
MX342986B (es) 2016-10-19
CN103189065B (zh) 2015-03-18
JP6250397B2 (ja) 2017-12-20
WO2012049045A1 (en) 2012-04-19
JP2013539770A (ja) 2013-10-28
AU2011315708A1 (en) 2013-04-18
US9168276B2 (en) 2015-10-27
MX2013004008A (es) 2013-04-24
PT2627345E (pt) 2014-09-04
HK1186671A1 (en) 2014-03-21
CN103189065A (zh) 2013-07-03
SI2627345T1 (sl) 2014-10-30
DK2627345T3 (da) 2014-09-01
RU2580643C2 (ru) 2016-04-10
KR101870979B1 (ko) 2018-06-25
BR112013008771B1 (pt) 2022-02-22
CA2814312A1 (en) 2012-04-19
RU2013121576A (ru) 2014-11-20
ITMI20101852A1 (it) 2012-04-12
EP2627345A1 (en) 2013-08-21
BR112013008771A2 (pt) 2021-04-20
KR20130142115A (ko) 2013-12-27
PL2627345T3 (pl) 2015-01-30
IL225668A (en) 2016-12-29
JP2016155878A (ja) 2016-09-01
EP2627345B1 (en) 2014-07-23
IT1402018B1 (it) 2013-08-28
CA2814312C (en) 2021-10-12
IL225668A0 (en) 2013-06-27
AR083366A1 (es) 2013-02-21
AU2011315708B2 (en) 2014-03-20
SG189345A1 (en) 2013-05-31
US20130280355A1 (en) 2013-10-24

Similar Documents

Publication Publication Date Title
ES2496892T3 (es) Formulaciones para el tratamiento de trastornos del tracto respiratorio superior
ES2512141T3 (es) Análogo peptídico de oxintomodulina
ES2488407T3 (es) Preparación farmacéutica que contiene lipasa de origen bacteriano
SV2010003581A (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
CL2011003115A1 (es) Producto farmaceutico solido para el diagnostico del cancer, afecciones precancerosas y afecciones no cancerosas en el tracto gastrointestinal inferior que comprende a) acido 5-aminolevulinico (5-ala), un precursor de 5-ala o un derivado de 5-ala, b) uno o mas trigliceridos y c) uno o mas emulsionadores.
ECSP17044282A (es) Formulación de relación fija de insulina glargina/lixisenatida
UY29395A1 (es) Formulación de medicamentos conteniendo vardenafilo.
PH12015502556A1 (en) Modified release formulation
MX2016011025A (es) Composiciones de grapiprant y metodos para usar las mismas.
ES2577405T3 (es) Composiciones para el tratamiento de úlceras periféricas de varios orígenes
CL2015001502A1 (es) Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma.
ECSP12011951A (es) Uso de una fuente de l3 y/o l5 como vacuna o como diagnóstico para una enfermedad parasitaria
CL2010001594A1 (es) Uso de nifurtimox para preparar un medicamento útil en el tratamiento de enfermedades causadas por trichomonadida.
ES2582854T3 (es) Uso de un agente para ensilaje para el tratamiento de remolachas no fragmentadas
CO7240380A2 (es) Composiciones líquidas orales pediátricas que contienen nepadutant
ES2550461T3 (es) Uso de S-adenosilmetionina (SAM) y superóxido dismutasa (SOD) para la preparación de medicamentos para el tratamiento de la enfermedad de Alzheimer
ES2554227T3 (es) Uso de un extracto natural de bagazo de uva para estimular las defensas naturales de las plantas
ES2501367B1 (es) Método de tratamiento de coccidiosis
ES2426017B1 (es) Microemulsión que comprende colagenasa y usos
AR130700A2 (es) Composiciones de grapiprant y métodos para su utilización
CL2013000210A1 (es) Compuestos derivados de tiofeno 2,3,5 trisustituidos; composición farmacéutica; combinación farmacéutica; y su uso para el tratamiento de un trastorno o enfermedad en un sujeto causado o asociado con una infeccion por vhc, tales como cirrosis hepatica, carcinoma hepatocelular, entre otras.
UA113771C2 (xx) Фармацевтична композиція у формі дерматологічної мазі для лікування алергічних і запальних захворювань шкіри
TH159856A (th) ยาเม็ดอมนุ่มที่มีสารสกัดจากหัวขมิ้นชัน
UA100709U (uk) Фармацевтична композиція для лікування запальних захворювань шлунково-кишкового тракту
CR11141A (es) Composiciones farmaceuticas y cosmetologicas con base de extracto de sanguijuelas medicinales y plantas medicinales sinergistas